Boston, MA -- (SBWIRE) -- 08/09/2012 -- Reasons to Get this ReportCID S.r.l. is a medical device company, based in Italy. The company researches and develops and proven clinical experience in the treatment of vascular disease. Its product portfolio includes DES+BIS, DES, BMS+BIS, BMS and PTCA. The company's PTCA products include fluydo, pro HP, brio, grip, across CTO OTW and across CTO RX. Its technologies include carbofilm, carbostent and reservoirs. The company patients include the heart, coronary artery disease, heart attack or myocardial infarction and treatment of coronary artery disease. It's products are certified by the International Organization of Standardization (ISO) 9001 and 13485 and the Canadian Medical Device Regulation. The company was incorporated in 1988. CID S.r.l is headquartered in Milan, Italy.

View Full Report Details and Table of Contents

This report is a source for data, analysis and actionable intelligence on the CID S.r.l. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Toscana Biomarkers Srl - Product Pipeline Analysis
- Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
- Siemens Healthcare - Product Pipeline Analysis
- bioMerieux S.A. (BIM) - Product Pipeline Analysis
- Philips Healthcare - Product Pipeline Analysis
- Quidel Corporation (QDEL) - Product Pipeline Analysis
- Siemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis
- MicroPort Scientific Corporation (853) - Product Pipeline Analysis
- Alere Inc. (ALR) - Product Pipeline Analysis
- Innovia LLC - Product Pipeline Analysis